and has been repeatedly confirmed by others (30, 31, 36, 43) in a wide variety of malignant diseases. This led investigators to identify abnormal fibrin metabolism associated with malignant disease that resulted in increased removal of fibrinogen from the circulation of experimental animals and patients with cancer(9,16,27,38) . This fibrin was deposited at the advancing margin ofthe solid tumors (6, 7, 17, 32) . In addition, fibrin was deposited on blood borne malignant cells that were thought to be potentially metastatic (4,5,2 1,24,44) . The administration of anticoagulants (29, 45, 46) and fibrinolysins (23, 46) 
